Abbott plans marketing push for glucose monitors beyond diabetes
By Leroy Leo and Puyaan Singh
July 18 (Reuters) -Abbott Laboratories ABT.N will use a mix of TV advertisements and guerilla marketing as well as seek to personalize health data to tap people without diabetes for the U.S. launch of its glucose monitoring device, CEO Robert Fordsaid on Thursday.
The company plans to launch the over-the-counter device, Lingo, this year. It could be a multi-billion-dollar product for Abbott, Ford estimated, adding it was still in its early days.
Lingo and Libre Rio, another of Abbott's devices,received clearance from the U.S. Food and Drug Administration's last month.
Lingo targets consumers who want to better understand their health, while Libre Rio is for adults with type 2 diabetes who do not need insulin.
Abbott is a key player in the marketfor continuous glucose monitors sold under prescription to diabetes patients, along with rivals DexCom DXCM.O and Medtronic MDT.N.
FreeStyle Libre, Abbott's blood sugar monitor, generated $1.6 billion in salesglobally in the second quarter. However,the company said the marketing for a consumer product would greatly differ from that for a medical device.
"I don't think, givenour experience here, that you can just go on TV, blast TV advertising and you'll get this big uptake. You are going to have to do some on-the-ground kind of guerilla marketing," Ford said during an analyst conference call.
Guerilla marketing uses tactics such ason-ground outreach, social media campaigns, among others, and usually involve low budgets.
Ford expects sales growth for Lingo to ramp up over time as the company builds the market.
RBC Capital Markets analyst Shagun Singh does not currently model much in sales of Abbott and Dexcom's OTC products, but believes the market would be significant.
Abbott is "literally just launching it this summer. So there will be a lot to learn for us, but substantial opportunities for both companies," said Singh.
Olympic athletes turn to diabetes tech in pursuit of medals https://www.reuters.com/sports/olympics/olympic-athletes-turn-diabetes-tech-pursuit-medals-2024-06-10/
Reporting by Leroy Leo and Puyaan Singh in Bengaluru; Editing by Shreya Biswas
Aloqador aktivlar
Eng oxirgi yangiliklar
Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.
Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi
Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.
